Innovation Pharmaceuticals Inc (IPIX)

[GrassyKnoll]

Perhaps your timeline is a bit off. The other company that many of us are invested in thanks to Patrick Cox looks like it’s getting things done in less than a year in a much more complicated disease Parkinson’s dementia and a trial of only 100 and some odd people. Because the population of the disease is limited accelerated approval is available to go directly from face to be to phase 4. Both IBD and 0M or similar in that the measurement criteria are pretty clear the druggist seems to work very well in the early trials and at least for IBD it’s going to Europe where the regulatory apparatus is not in deep-freeze it looks like our potential partner is in Europe and wants us to proceed there or maybe we don’t have a partner and the management here learned from the other company that that’s the place to be for now con these are not like cancer trials in the old-school way where it took for ever and it’s not like child’s where the drug barely worked and you had to have large numbers or trails for you wanted to see if you could move a large population and then had large numbers. These are clear cut indications of clear-cut measurements are relatively clear cut with small populations and therapies are already have significant confidence from very small number trials so no we could have approval within a year